HOME / SERVICES / LICENSED MEDICINE DISTRIBUTION
Licensed Medicine Distribution
We understand that enabling timely access to a therapy for patients can be challenging for many pharmaceutical companies.
These challenges include:
-
Unable to commercialise due to a lack of footprint.
-
A lack of resources and regional knowledge in a particular territory.
-
Delayed launch in some countries or not at all in others.
-
A decision to withdraw from a market.
-
Providing access via suitable unlicensed channels where commercialisation is not viable.
Partnering could be a viable solution to enable access, via flexible distribution models. A partner that can be trusted to address the challenge and maximise value and grow revenue through optimising access.
We support healthcare systems by delivering licensed medicines through focused, compliant and transparent distribution pathways.
Our Partnering Approach
Raphaela Pharma offers an subsidiary-style partnership model, acting as an extension of our client's businesses. We provide expert input and strategic insights to the most effective approach for each product in the regions we serve.
Our experience and expertise enables us to deliver in-depth insights and honest, practical recommendations aligned with our clients' needs.
Product Lifecycle Focus
Within the therapeutic areas we specialise in, we have the experience to commercialise and distribute both newly developed and established therapies, including tail-end products. This enables us to deliver tailored solutions for both licensed and unlicensed access in our region.
